k418 - page 459

ВестникНОМУС
.
Сборникматериалов
конкурса
литературных
обзоров
-2012
459
24.
Cystic Fibrosis Foundation, Patient Registry 2009 Annual Report, Cystic
Fibrosis Foundation, Bethesda,Md, USA.- 2011.
25.
Döring G. For the Consensus Study Group. Early intervention and prevention
of lung disease in cystic fibrosis: aEuropean consensus / G. Döring // JCyst Fibros. –
2004. -
3. -
Р
.67–91.
26.
Geller D.E. Levofloxacin Inhalation Solution (MP-376) in Patients withCystic
Fibrosis with Pseudomonas aeruginosa / D.E. Geller [et al.] // Am J Respir Crit Care
Med. –2011. -
183, (11). -
Р
.1510–1516.
27.
Gibson R.L. Duration of treatment effect after tobramycin solution for
inhalation in young children with cystic fibrosis / R.L. Gibson [et al.] // Pediatr
Pulmonol. –2007. -
42. -
Р
.610–623.
28.
Grasemann H. Inhalation of moli1901 in patients with cystic fibrosis / H.
Grasemann [et al.] // Chest. – 2007. -
131. -
Р
.1461–1466.
29.
Jelsbak L. Molecular epidemiology and dynamics of Pseudomonas aeruginosa
populations in lungs of cystic fibrosis patients / L. Jelsbak // Infect. Immun. – 2007. -
75. - P. 2214-2224.
30.
Kerem E. Mutation specific therapy in CF/ E. Kerem //Paediatr Respir Rev. -
2006. -
7, (1). - P.166–169.
31.
Littlewood J. Looking back over 40 years (part I). / J. Littlewood // CFW
Newsletter. – 2004. -
4, (2). –
Р
. 39—50.
32.
Proesmans M. What's new in cystic fibrosis? From treating symptoms to
correction of the basic defect/M. Proesmans [et al.] // Eur J Pediatr. – 2008. -
167,
(8). -
Р
.839–849.
33.
Retsch-Bogart G.Z. Phase 3 trial (AIR-CF1) measuring improvement in
respiratory symptoms in patients with cystic fibrosis (CF) following treatment with
aztreonam lysine for inhalation (AZLI) / G.Z. Retsch-Bogart [et al.] //. Pediatr
Pulmonol. –2007. -
42,(30). -
Р
.310.
34.
Stephens S. E. Cystic fibrosis and renal disease/ S.E. Stephens, S.P. Rigden //
PaediatrRespirRev. – 2002. -
3, (2). -
Р
.135-138.
35.
Sarles J. Blood concentrations of pancreatitis associated protein in neonates:
relevance to neonatal screening for cystic fibrosis. / J. Sarles [et al.] // ArchDisChild
Fetal Neonatal Ed. –2003. -
80, (2). -
Р
.118–122.
1...,449,450,451,452,453,454,455,456,457,458 460,461,462,463,464,465,466,467,468,469,...663
Powered by FlippingBook